New Ebola vaccine trial launches as outbreak spreads in DR Congo
Clinical trial of the Zaire Ebolavirus vaccine Ervebo to be investigated against the current Bundibugyo strain. O recorte ajuda a contextualizar a pauta dentro de Viagem.
Notícias
Acompanhe as Notícias da Recifes
Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.
WHO urges Ervebo vaccine trial in DR Congo Ebola outbreak
WHO vaccine experts on Friday recommended a full-scale human trial of the only existing approved Ebola vaccine to see if it offers cross-protection against a deadly strain spreading in the DR Congo.
DR Congo: Could a vaccine soon be available to the public?
The Ervebo vaccine has proved safe and effective against the more common Zaire strain of the Ebola virus, and World Health Organization experts say early data, notably from animal trials, suggest it may also offer some protection against the rarer Bundibugyo strain, which is spre